Melody® Transcatheter Pulmonary Valve Post-Approval Study

NACompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

October 31, 2017

Conditions
Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit
Interventions
DEVICE

Melody® Transcatheter Pulmonary Valve

Transcatheter Pulmonary Valve replacement Transcatheter valve implantation into a RVOT conduit in patients with complex congenital heart defects where the conduit has become dysfunctional and where the patient needs invasive intervention.

Trial Locations (10)

15201

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

48109

CS Mott Children's Hospital, University of Michigan, Ann Arbor

48201

Children's Hospital of Michigan, Detroit

55905

Mayo Clinic, Rochester

60453

Advocate Hope Children's Hospital, Oak Lawn

63110

St. Louis Children's Hospital, St Louis

75235

Children's Medical Center Dallas, UT Southwestern, Dallas

84113

Primary Children's Medical Center, University of Utah, Salt Lake City

92123

Rady Children's Hospital, San Diego

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT01186692 - Melody® Transcatheter Pulmonary Valve Post-Approval Study | Biotech Hunter | Biotech Hunter